Evidence map›Paper›PMID 40403730›Full record

ArticleCell genomics2025

Evaluating methods for the prediction of cell-type-specific enhancers in the mammalian cortex.

Nelson J Johansen, Niklas Kempynck, Nathan R Zemke, Saroja Somasundaram, Seppe De Winter, Marcus Hooper, Deepanjali Dwivedi, Ruchi Lohia, Fabien Wehbe, Bocheng Li and 24 more

Abstract read
In one paragraph

Article in Cell genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cross-species consensus atlas of the primate basal ganglia.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Nelson J JohansenAllen Institute for Brain Science, Seattle, WA 98109, USA.
Niklas KempynckVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Nathan R ZemkeCenter for Epigenomics, Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Saroja SomasundaramAllen Institute for Brain Science, Seattle, WA 98109, USA.
Seppe De WinterVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Marcus HooperAllen Institute for Brain Science, Seattle, WA 98109, USA.
Deepanjali DwivediAllen Institute for Brain Science, Seattle, WA 98109, USA.
Ruchi LohiaPhysiology Department and Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
Fabien WehbeMaisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, QC, Canada.
Bocheng LiSchool of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
Darina AbaffyováVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Ethan J ArmandBioinformatics and Systems Biology Program, University of California, San Diego, La Jolla, CA 92093, USA.
Julie De ManVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Eren Can EkşiVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Nikolai HeckerVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Gert HulselmansVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Vasilis KonstantakosVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
David MauduitVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
John K MichAllen Institute for Brain Science, Seattle, WA 98109, USA.
Gabriele PartelVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Tanya L DaigleAllen Institute for Brain Science, Seattle, WA 98109, USA.
Boaz P LeviAllen Institute for Brain Science, Seattle, WA 98109, USA.
Kai ZhangSchool of Life Sciences, Westlake University, Hangzhou, Zhejiang, China; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Yoshiaki TanakaMaisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, QC, Canada.
Jesse GillisPhysiology Department and Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
Jonathan T TingAllen Institute for Brain Science, Seattle, WA 98109, USA; Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195, USA.
Yoav Ben-SimonAllen Institute for Brain Science, Seattle, WA 98109, USA.
Jeremy MillerAllen Institute for Brain Science, Seattle, WA 98109, USA.
Joseph R EckerSalk Institute for Biological Studies, La Jolla, CA 92037, USA.
Bing RenCenter for Epigenomics, Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Stein AertsVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Ed S LeinAllen Institute for Brain Science, Seattle, WA 98109, USA.
Bosiljka TasicAllen Institute for Brain Science, Seattle, WA 98109, USA.
Trygve E BakkenAllen Institute for Brain Science, Seattle, WA 98109, USA. Electronic address: trygveb@alleninstitute.org.

Funding

Center for Integrated Multi-modal and Multi-scale Nucleome ResearchUM1HG011585 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DULAC, CATHERINE, LEIN, ED · 2020 to 2024
$6.7M
NHGRI NIH HHS UM1 HG011585
6 · The paper itself

Abstract

Identifying cell-type-specific enhancers is critical for developing genetic tools to study the mammalian brain. We organized the "Brain Initiative Cell Census Network (BICCN) Challenge: Predicting Functional Cell Type-Specific Enhancers from Cross-Species Multi-Omics" to evaluate machine learning and feature-based methods for nominating enhancer sequences targeting mouse cortical cell types. Methods were assessed using in vivo data from hundreds of adeno-associated virus (AAV)-packaged, retro-orbitally delivered enhancers. Open chromatin was the strongest predictor of functional enhancers, while sequence models improved prediction of non-functional enhancers and identified cell-type-specific transcription factor codes to inform in silico enhancer design. This challenge establishes a benchmark for enhancer prioritization and highlights computational and molecular features critical for identifying functional cortical enhancers, advancing efforts to map and manipulate gene regulation in the mammalian cortex.

Indexed as

Cerebral CortexEnhancer Elements, GeneticAnimalsChromatinComputational BiologyDependovirusMachine LearningMiceChromatinATAC-seqcortexcross-speciesDNA sequence modelenhancer-AAVprediction benchmarksingle-cell multiomicsTF codes

Identifiers

PMID40403730
PMCPMC12230242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.